Thoughts on the Three Stooges

Quote
Anonymous said:
Wow, touchy, touchy. So routine supply will make them mad? Performance based discounts will piss them off? A big DTC campaign that will send patients in asking for the vaccines will push them over a cliff?

i'm not rocket scientist like you, but i think 2012 could be a descent year for once with Zostavax....for those who have been with this vaccine since launch, they know what I mean.
Click to expand...

Go ask all your retail pharmacists how much Zostavax they are sitting on from last year and then add the 2012 80% growth on top of that. We shall see if this will be a decent (respectable) year for Zostavax or a descent (downward) year for Zostavax. You stated, "i think 2012 will be a descent year" so maybe you are not too optimistic or you just don't know how to spell.
 




Anonymous said:
Go ask all your retail pharmacists how much Zostavax they are sitting on from last year and then add the 2012 80% growth on top of that. We shall see if this will be a decent (respectable) year for Zostavax or a descent (downward) year for Zostavax. You stated, "i think 2012 will be a descent year" so maybe you are not too optimistic or you just don't know how to spell.
Click to expand...

Good catch on the typo....maybe its a subliminal message.

Not sure what's going on in your area, but my pharmacies have doses from last year, but not a ton. Some of the chains ordered a lot, but they're big boys and girls who made that decision and we got credit for those doses last year and that's showing up in my bonus next week. maybe i'm an outlier, but i think these doses will move and if the DTC campaign is effective i just need to get my customers to have the right conversation with patients who are asking about the vaccine.

i alos agree with some of the other posts...it would be easier if we were still in PC and PED - there is plenty of work to go around!
 




Anonymous said:
Good catch on the typo....maybe its a subliminal message.

Not sure what's going on in your area, but my pharmacies have doses from last year, but not a ton. Some of the chains ordered a lot, but they're big boys and girls who made that decision and we got credit for those doses last year and that's showing up in my bonus next week. maybe i'm an outlier, but i think these doses will move and if the DTC campaign is effective i just need to get my customers to have the right conversation with patients who are asking about the vaccine.

i alos agree with some of the other posts...it would be easier if we were still in PC and PED - there is plenty of work to go around!
Click to expand...

O.P. here. Not trying to be a hater and that's cool your retail pharmacies are moving doses. However, I have talked others who have some chains that ordered a ton in 2011 and are still sitting on a lot this year. We are being pulled in so many directions right now its hard to focus on retail pharmacies, pc offices and pediatrics. We were aligned just fine before the multi- specialty role but some people wanted to shake things up to look good at our expense. We work harder not smarter and it should be the other way around.
 




Anonymous said:
The tablet chuckers merely looked at MVD as a place to dig in their claws and look what happened.
Click to expand...

They keep trying out new pilot programs and trying to expand more mgam type positions so that more management from USHH can escape and exploit vaccines even further. USHH is about dead from tablet incompetence virus (TIV) and the virus has spread to vaccines.
 




Anonymous said:
Until all three are officially gone, this thread will keep coming back too. Mike, Margie and Alina, the axis of evil to MVD. Anyone beg to differ?
Click to expand...

I think the thread needs to stay so history doesn't repeat itself. Oh wait, we have the little rascals now which is just a younger and dumber version of the original three. We are truly doomed.
 




Anonymous said:
With Singulair going off patent, I can smell another needless vaccine expansion, then optimization within two years. Merck never bothers to learn from it's mistakes. They just keep making bigger ones every chance they get.
Click to expand...

The MGAM role may be expanded so that more managers can find safe haven if there are more layoffs, so Merck hasn't learned its lesson. What a shame.
 




Anonymous said:
The little rascals are driving drunk. Just sit on the side and watch them panic as the year progresses and the objectives are falling more and more beyond their reach.
Click to expand...

The panic is starting. The nation is below plan for Zostavax already and pressure is coming from above to move last years doses that are still sitting in fridges.
 




Anonymous said:
The panic is starting. The nation is below plan for Zostavax already and pressure is coming from above to move last years doses that are still sitting in fridges.
Click to expand...

Typical Merck. An executive decision is made to oversell the retail pharmacies without any realistic sales input and the field gets blamed. This is comical how bad this current leadership has scewed things up. They are actually moving at a faster pace than the stooges.
 




Anonymous said:
The panic is starting. The nation is below plan for Zostavax already and pressure is coming from above to move last years doses that are still sitting in fridges.
Click to expand...

No concrete plan to defend Pneumovax 23 or MMRII from competition. Yeah, dragging your heals on a plan to defend against vaccine competition is really going to help the division to meet the goal of 10 billion by 2020. Let me guess, are you going to hire yet another consulting firm to bail you out? Monitor and Partners In Leadership are already making millions off of Merck.

I couldn't make this next part up. The Monitor Group who provides consultation services for Merck also provided services for M. Gaddafi between 2006 and 2008. Google for yourself if you don't believe. Apparently, Monitor specializes in making dictatorships appear to look better than they really are. How sad is that?
 




Anonymous said:
Strategic planning seems to be still another thing that left with the MVD people. I don't recall panic mode, disorganization, or folks leading who were clueless about exactly what they were leading us into.
Click to expand...

Contract and VFC knowledge is at an all time low as well. Backstabbing, brown nosing and b.s. business plans with few customer interactions is the sad norm now.
 




Anonymous said:
Contract and VFC knowledge is at an all time low as well. Backstabbing, brown nosing and b.s. business plans with few customer interactions is the sad norm now.
Click to expand...

I have heard leadership under Alina say MVD was asleep at the wheel when they were in charge. Then, we have retarded drunken monkeys driving MVID into a drainage ditch now.
 




Anonymous said:
Good catch on the typo....maybe its a subliminal message.

Not sure what's going on in your area, but my pharmacies have doses from last year, but not a ton. Some of the chains ordered a lot, but they're big boys and girls who made that decision and we got credit for those doses last year and that's showing up in my bonus next week. maybe i'm an outlier, but i think these doses will move and if the DTC campaign is effective i just need to get my customers to have the right conversation with patients who are asking about the vaccine.

i alos agree with some of the other posts...it would be easier if we were still in PC and PED - there is plenty of work to go around!
Click to expand...

Pfizer is going after thought leaders and hospital P&T committees to con them into believing Prevnar 13 is a better adult vaccine than Pneuomvax 23. GSK is revamping it's VPA and putting more boots on the ground to grow their pediatric franchise with their MMR coming out end of this year.

What is Merck doing? Trying to sell us on a new Oz culture, distracting us with meetings where EVERYBODY has to speak up or get a PIP, forcing us to create over written strategy plans and ensuring we stay ludicrously laser focused on one vaccine Zostavax. How is it working out? Culture sucks, reps disenchanted and we are way behind on Zostavax. MVID's plan to win is failing. What a slow agonizing trainwreck this is.
 




Anonymous said:
Pfizer is going after thought leaders and hospital P&T committees to con them into believing Prevnar 13 is a better adult vaccine than Pneuomvax 23. GSK is revamping it's VPA and putting more boots on the ground to grow their pediatric franchise with their MMR coming out end of this year.

What is Merck doing? Trying to sell us on a new Oz culture, distracting us with meetings where EVERYBODY has to speak up or get a PIP, forcing us to create over written strategy plans and ensuring we stay ludicrously laser focused on one vaccine Zostavax. How is it working out? Culture sucks, reps disenchanted and we are way behind on Zostavax. MVID's plan to win is failing. What a slow agonizing trainwreck this is.
Click to expand...

Don't forget outsourcing rep positions to inVentive or rely more heavily on wholesalers.
 




Anonymous said:
The MGAM role may be expanded so that more managers can find safe haven if there are more layoffs, so Merck hasn't learned its lesson. What a shame.
Click to expand...

Even worse, most of the reps know more about vaccines and contracts than these MGAMs do and they get paid a lot more. Morale is so low here because we are top heavy with idiots in management looking out for themselves .
 




















Anonymous said:
The fact that the ignorant rascals may be influencing Todd who knows nothing about vaccines means things are going to get much worse.
Click to expand...

Case in point, the 2012 Zostavax numbers. If they would have listened to the field, maybe retail pharmacies wouldn't still be overstocked. Thanks for killing the alleged adult vaccine potential. You want to move doses, lower the price.
 








Top Bottom
Back
Quote